HPG
Harvest Portfolios Group Portfolio holdings
AUM
$4.3B
This Quarter Return
-4.21%
1 Year Return
+16.34%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3B
AUM Growth
+$3B
(-0.54%)
Cap. Flow
+$137M
Cap. Flow
% of AUM
4.58%
Top 10 Holdings %
Top 10 Hldgs %
31.29%
Holding
244
New
3
Increased
121
Reduced
104
Closed
12
Top Buys
| 1 |
NVIDIA
NVDA
|
$34M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
$30.4M |
| 3 |
Eli Lilly
LLY
|
$28.2M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$25M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$19.3M |
Top Sells
| 1 |
SPDR Portfolio Long Term Treasury ETF
SPTL
|
$23.5M |
| 2 |
Broadcom
AVGO
|
$16.9M |
| 3 |
Boston Scientific
BSX
|
$15.6M |
| 4 |
Bristol-Myers Squibb
BMY
|
$14.1M |
| 5 |
Stryker
SYK
|
$9.48M |
Sector Composition
| 1 | Healthcare | 37.54% |
| 2 | Technology | 21.66% |
| 3 | Financials | 5.81% |
| 4 | Communication Services | 3.89% |
| 5 | Consumer Discretionary | 3.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares 20+ Year Treasury Bond ETF
TLT
$47.8B
| $265M | 8.85% |
3,039,534
+285,825
| +10% | +$25M |
|
|
2
iShares 7-10 Year Treasury Bond ETF
IEF
$35.7B
| $119M | 3.97% |
1,285,965
+329,248
| +34% | +$30.4M |
|
|
3
Eli Lilly
LLY
$657B
| $94.9M | 3.16% |
122,892
+36,587
| +42% | +$28.2M |
|
|
4
NVIDIA
NVDA
$4.24T
| $90.7M | 3.03% |
675,688
+253,463
| +60% | +$34M |
|
5
Johnson & Johnson
JNJ
$427B
| $71.2M | 2.38% |
492,465
+22,491
| +5% | +$3.25M |
|
6
UnitedHealth
UNH
$281B
| $69.1M | 2.31% |
136,633
+9,843
| +8% | +$4.98M |
|
7
Microsoft
MSFT
$3.77T
| $66.6M | 2.22% |
157,915
+33,500
| +27% | +$14.1M |
|
8
Merck
MRK
$210B
| $53.9M | 1.8% |
542,156
+42,248
| +8% | +$4.2M |
|
9
AbbVie
ABBV
$372B
| $53.8M | 1.79% |
302,788
+29,577
| +11% | +$5.26M |
|
10
Amgen
AMGN
$155B
| $53.6M | 1.79% |
205,491
+34,152
| +20% | +$8.9M |
|
11
AstraZeneca
AZN
$248B
| $53.3M | 1.78% |
814,078
+85,891
| +12% | +$5.63M |
|
|
12
Bristol-Myers Squibb
BMY
$96B
| $52.8M | 1.76% |
932,645
-249,553
| -21% | -$14.1M |
|
13
Elevance Health
ELV
$71.8B
| $52.1M | 1.74% |
141,148
+37,960
| +37% | +$14M |
|
14
Danaher
DHR
$147B
| $51.8M | 1.73% |
225,849
+23,586
| +12% | +$5.41M |
|
15
Agilent Technologies
A
$35.7B
| $51.8M | 1.73% |
385,841
+10,921
| +3% | +$1.47M |
|
16
Thermo Fisher Scientific
TMO
$186B
| $51.7M | 1.72% |
99,326
+7,786
| +9% | +$4.05M |
|
17
Novartis
NVS
$245B
| $51.6M | 1.72% |
530,340
+32,077
| +6% | +$3.12M |
|
18
Medtronic
MDT
$119B
| $51.5M | 1.72% |
645,045
-44,086
| -6% | -$3.52M |
|
|
19
Boston Scientific
BSX
$156B
| $51.4M | 1.72% |
575,975
-174,241
| -23% | -$15.6M |
|
20
Zoetis
ZTS
$69.3B
| $51.4M | 1.72% |
315,591
+9,491
| +3% | +$1.55M |
|
|
21
Stryker
SYK
$150B
| $51.4M | 1.71% |
142,646
-26,338
| -16% | -$9.48M |
|
22
Abbott
ABT
$231B
| $51.3M | 1.71% |
453,778
-73,354
| -14% | -$8.3M |
|
|
23
Regeneron Pharmaceuticals
REGN
$61.5B
| $50.8M | 1.7% |
71,369
+27,029
| +61% | +$19.3M |
|
24
Intuitive Surgical
ISRG
$170B
| $50.6M | 1.69% |
96,875
-6,823
| -7% | -$3.56M |
|
25
Vanguard Long-Term Treasury ETF
VGLT
$9.84B
| $45.9M | 1.53% |
829,627
-139,286
| -14% | -$7.71M |
|